News

Yahoo Finance1y
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Oral mucositis, also called "chemo mouth," has emerged as the most significant ... CA / ACCESSWIRE / April 16, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it has ...
Yahoo Finance2mon
Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
"Jaguar's mission is to change patients' lives ... Oral mucositis, also called "chemo mouth," is among the most common, painful, and debilitating cancer treatment-related side effects, and it ...